Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

25.35
-0.4900-1.90%
Pre-market: 27.001.65+6.51%08:16 EDT
Volume:21.90M
Turnover:565.28M
Market Cap:5.63B
PE:47.63
High:26.70
Open:26.49
Low:25.13
Close:25.84
Loading ...

Stock Track | Hims & Hers Plunges Over 18% After-Hours on Concerns Over Weight Loss Drug Business

Stock Track
·
25 Feb

Hims & Hers Stock Tumbles Despite Beating Expectations

Dow Jones
·
25 Feb

Stocks to Watch: Hims & Hers Health, Chegg, Wah Fu Education Group

Dow Jones
·
25 Feb

Hims & Hers Expects Customers to Return to Branded Weight Loss Drugs -- Market Talk

Dow Jones
·
25 Feb

Hims & Hers warns it may stop selling compounded weight-loss drugs

Reuters
·
25 Feb

BRIEF-Hims & Hers Health FDA Resolved Semaglutide Shortage

Reuters
·
25 Feb

Hims & Hers Health, Inc. (HIMS) Lags Q4 Earnings Estimates

Zacks
·
25 Feb

Hims & Hers warns its supply of compounded weight loss drugs could be 'constrained'

Reuters
·
25 Feb

Hims & Hers Health: FDA Resolved Semaglutide Shortage, Which Could Constrain Co's Ability to Continue Providing Access to Compounded Semaglutide

THOMSON REUTERS
·
25 Feb

Hims & Hers Shares Sink Despite Upbeat Earnings, Outlook

Dow Jones
·
25 Feb

Hims & Hers Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Hims & Hers Q4 Earnings, Revenue Rise; Issues Outlook; Shares Fall After-Hours

MT Newswires Live
·
25 Feb

HIMS Earnings: Shares Sink despite Smashing Guidance Estimates

TIPRANKS
·
25 Feb

Stock Track | Hims & Hers Health Plunges 20% After-Hours Despite Q4 Earnings Beat on Growth Outlook Miss

Stock Track
·
25 Feb

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Benzinga
·
25 Feb

Hims & Hers Health Q4 2024 GAAP EPS $0.11, Inline, Sales $481.14M Beat $470.31M Estimate

Benzinga
·
25 Feb

Hims & Hers Health Drops 14.3% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Guides For Q1 Revenue of $520-$540 Million, vs FactSet Analyst Consensus of $497 Million

MT Newswires Live
·
25 Feb

BRIEF-Hims & Hers Health Q4 Revenue USD 481.1 Million Vs. IBES Estimate USD 470.3 Million

Reuters
·
25 Feb

Hims & Hers Health Q4 Gross Margin 77%

THOMSON REUTERS
·
25 Feb